Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 435 shares were traded during trading, a decline of 40% from the previous session’s volume of 725 shares.The stock last traded at $9.79 and had previously closed at $10.20.
Ambu A/S Stock Performance
The company has a 50-day moving average price of $10.24 and a two-hundred day moving average price of $11.95. The company has a current ratio of 2.92, a quick ratio of 1.73 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.30 billion, a P/E ratio of 34.96 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.The firm had revenue of $246.39 million during the quarter.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Articles
- Five stocks we like better than Ambu A/S
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
